Ascend Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-45,525
| Closed | -$4.49M | – | 169 |
|
|
2018
Q2 | $4.49M | Buy |
+45,525
| New | +$4.49M | 0.21% | 113 |
|
|
2016
Q2 | – | Sell |
-40,000
| Closed | -$2.51M | – | 142 |
|
|
2016
Q1 | $2.51M | Sell |
40,000
-10,000
| -20% | -$628K | 0.24% | 79 |
|
|
2015
Q4 | $4.71M | Buy |
+50,000
| New | +$4.71M | 0.17% | 105 |
|